SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009427
Filing Date
2017-05-08
Accepted
2017-05-08 16:44:02
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q omed-10q_20170331.htm 10-Q 1127163
2 EX-31.1 omed-ex311_7.htm EX-31.1 16485
3 EX-31.2 omed-ex312_6.htm EX-31.2 16518
4 EX-32.1 omed-ex321_8.htm EX-32.1 8480
  Complete submission text file 0001564590-17-009427.txt   4335585

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT omed-20170331.xml EX-101.INS 890897
6 XBRL TAXONOMY EXTENSION SCHEMA omed-20170331.xsd EX-101.SCH 38997
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20170331_cal.xml EX-101.CAL 30113
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20170331_def.xml EX-101.DEF 139918
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20170331_lab.xml EX-101.LAB 266524
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20170331_pre.xml EX-101.PRE 235285
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 17823036
SIC: 2834 Pharmaceutical Preparations